GSK and CureVac restructure partnership in new licensing agreement | GSK

GSK acquires full rights to globally develop, manufacture and commercialize mRNA vaccine candidates for influenza and COVID-19, including combinations CureVac to receive €400 million upfront and up to €1.05 billion additional in development, regulatory and sales milestone payments, as well as tiered royalties; replacing all previous financial considerations from the prior collaboration agreement GSK plc … Read more

Adobe is revising its terms of use to clarify content licensing, AI and privacy

The image features the Adobe logo with "Adobe" written next to it in white. The background is a vibrant, multicolored abstract design with hues of red, yellow, orange, and blue.

The confusion and anger surrounding an update to Adobe’s terms of use last week caused Adobe to reexamine its language and communications in general. In addition to a blog post late last week, Adobe published another blog post today announcing plans for direct customer communications and updated terms of use. “We recently introduced a re-acceptance … Read more